BIOMARIN PHARMACEUTICAL INC (BMRN) Gross margin 2016–2025
BIOMARIN PHARMACEUTICAL INC (BMRN) gross margin by fiscal year — reported gross profit divided by reported revenue.
77.7%FY2025 · since FY2016: 81.2% → 77.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 77.7% | -1.9 pp |
| FY2024 | 79.7% | +1.7 pp |
| FY2023 | 78.0% | +2.0 pp |
| FY2022 | 76.0% | +1.5 pp |
| FY2021 | 74.5% | +2.7 pp |
| FY2020 | 71.8% | -7.1 pp |
| FY2019 | 78.9% | +0.0 pp |
| FY2018 | 78.9% | -2.7 pp |
| FY2017 | 81.6% | +0.4 pp |
| FY2016 | 81.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice